| Literature DB >> 27164618 |
James Hodge1, Howard H Chang, Sophie Boisson, Simon M Collin, Rachel Peletz, Thomas Clasen.
Abstract
BACKGROUND: Fecally contaminated drinking water is believed to be a major contributor to the global burden of diarrheal disease and a leading cause of mortality among young children. However, recent systematic reviews and results from blinded studies of water quality interventions have raised questions about the risk associated with fecally contaminated water, particularly as measured by thermotolerant coliform (TTC) bacteria, a WHO-approved indicator of drinking water quality.Entities:
Year: 2016 PMID: 27164618 PMCID: PMC5047765 DOI: 10.1289/EHP156
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Description of studies from which data were obtained and analyzed.
| Reference | Country | Study design | Cited water quality measurement method | Case definition | Recall period for self-reported diarrhea |
|---|---|---|---|---|---|
| Clasen et al. 2005 | Colombia | RCT | APHA | 3+ Loose stools / 24 hr | 7 Days |
| Clasen et al. 2006 | Bolivia | RCT | APHA | 3+ Loose stools / 24 hr | 7 Days |
| Clasen et al. 2014 | India | RCT | APHA | WHO | 7 Days |
| Boisson et al. 2009 | Ethiopia | RCT | Not specified | Local term “tekmat” | 7 Days |
| Boisson et al. 2010 | DR Congo | RCT | APHA | 3+ Loose stools / 24 hr | 7 Days |
| Peletz et al. 2011 | Zambia | Cross-sectional | Not specified | WHO | 7 Days |
| Peletz et al. 2012 | Zambia | RCT | APHA | WHO | 7 Days |
|
Abbreviations: APHA, American Public Health Association; RCT, randomized, controlled trial; WHO, World Health Organization. | |||||
Characteristics of individual studies included in aggregated data set.
| Characteristics | Cross-sectional | Randomized controlled trials | Combined | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Zambia CS | Ethiopia | Colombia | Bolivia | Zambia RCT | DR Congo | India | All studies | All exc. India | |
| Population | |||||||||
| Total households | 254 | 314 | 137 | 59 | 120 | 231 | 2,902 | 4,017 | 1,115 |
| Total individuals | 1,246 | 1,516 | 681 | 317 | 615 | 1,104 | 21,039 | 26,518 | 5,479 |
| Age | |||||||||
| Mean ± SD | 15.6 ± 14.3 | 21.8 ± 18.3 | 19.0 ± 16.8 | 20.8 ± 19.1 | 14.8 ± 14.3 | 21.6 ± 18.5 | 26.8 ± 20.9 | 26.5 ± 20.4 | 19.3 ± 17.2 |
| Median | 11 | 16 | 14 | 14 | 10 | 16 | 26 | 25 | 14 |
| < 5 (%) | 374 (31.9) | 196 (12.9) | 142 (20.9) | 60 (19.0) | 193 (34.0) | 185 (16.8) | 4,298 (20.8) | 5,448 (20.9) | 1,150 (21.5) |
| 5–15 (%) | 307 (26.1) | 534 (35.2) | 231 (34.0) | 108 (34.2) | 155 (27.3) | 348 (31.6) | 2,723 (13.1) | 4,406 (16.9) | 1,683 (31.4) |
| > 16 (%) | 493 (42.0) | 786 (51.8) | 307 (45.1) | 148 (46.8) | 220 (38.7) | 568 (51.6) | 13,691 (66.1) | 16,213 (62.2) | 2,522 (47.1) |
| Follow-up rounds | — | — | 3 | 2 | 12 | 14 | 10 | 14 | 14 |
| Diarrhea | |||||||||
| Baseline DD prevalence | 13.2 | 8.52 | 21.8 | — | 11.9 | 11.8 | — | 12.5 | 12.5 |
| Mean DD prevalence ± SD | — | — | 7.3 ± 3.2 | 3.9 ± 0.1 | 2.3 ± 1.5 | 2.8 ± 1.5 | 4.4 ± 2.4 | 3.7 ± 2.3 | 2.9 ± 1.8 |
| Total DD observations | 1,246 | 1,517 | 2,736 | 634 | 7,588 | 3,970 | 179,690 | 197,381 | 17,691 |
| Observations with DD and WQ | 1,083 | 1,159 | 1,977 | 542 | 6,131 | 3,681 | 30,479 | 45,052 | 14,573 |
| Season | |||||||||
| Dry (%) | 174 (14.0) | 1,470 (96.9) | 597 (21.8) | 634 (100) | 3,430 (50.4) | 1,970 (49.6) | 25,321 (14.1) | 33,596 (17.1) | 8,275 (48.9) |
| Rainy (%) | 1,072 (86.0) | 47 (3.1) | 2,139 (78.2) | 0 (0.0) | 3,375 (49.6) | 2,000 (50.4) | 154,369 (85.9) | 163,002 (82.9) | 8,633 (51.1) |
| Study arm | |||||||||
| Intervention | — | 748 (49.3) | 1,676 (61.3) | 408 (67.0) | 3,765 (49.6) | 1,928 (48.6) | 88,581 (49.4) | 97,106 (49.3) | 7,377 (48.7) |
| Control | — | 769 (50.7) | 1,060 (38.7) | 201 (33.0) | 3,823 (50.4) | 2,042 (51.4) | 90,785 (50.6) | 99,935 (50.7) | 7,785 (51.3) |
| Abbreviations: CS, cross-sectional; DD, diarrheal disease; RCT, randomized, controlled trial; WQ, water quality. | |||||||||
Total cases of diarrhea, total observations, and prevalence for each study by category.
| Category | Cases/observations (prevalence) | |||||||
|---|---|---|---|---|---|---|---|---|
| Colombia | Bolivia | Zambia CS | Zambia RCT | Ethiopia | DR Congo | India | All studies | |
| Total | 281/2,441 (11.5%) | 23/592 (3.9%) | 163/1,236 (13.2%) | 222/6,671 (3.3%) | 128/1,500 (8.5%) | 187/3,690 (5.1%) | 6,800/156,357 (4.3%) | 7,804/164,683 (4.5%) |
| Age category | ||||||||
| < 5 | 130/501 (25.9%) | 16/114 (14.0%) | 83/372 (22.3%) | 167/2,045 (8.2%) | 28/194 (14.4%) | 87/624 (13.9%) | 2,616/26,446 (9.9%) | 3,127/30,296 (10.3%) |
| 5–15 | 85/822 (10.3%) | 4/205 (2.0%) | 25/306 (8.2%) | 19/1,721 (1.1%) | 35/533 (6.6%) | 29/1,214 (2.4%) | 901/26,733 (3.4%) | 1,098/31,534 (3.5%) |
| > 15 | 64/1,105 (5.8%) | 3/271 (1.1%) | 48/488 (9.8%) | 32/2,396 (1.3%) | 65/773 (8.4%) | 71/1,843 (3.9%) | 3,283/103,171 (3.2%) | 3,566/110,047 (3.2%) |
| TTC category | ||||||||
| < 1 | 41/590 (6.9%) | 11/345 (3.2%) | 44/341 (12.9%) | 41/2,111 (1.9%) | 11/219 (5.0%) | 37/1,053 (3.5%) | 384/9,749 (3.9%) | 569/14,408 (3.9%) |
| 1–10 | 24/342 (7.0%) | 1/50 (2.0%) | 8/97 (8.2%) | 23/986 (2.3%) | 9/69 (13.0%) | 14/430 (3.3%) | 70/1,901 (3.7%) | 149/3,875 (3.8%) |
| 11–100 | 74/602 (12.3%) | 5/97 (5.2%) | 14/148 (9.5%) | 39/1,232 (3.2%) | 24/370 (6.5%) | 20/265 (7.5%) | 211/5,466 (3.9%) | 387/8,180 (4.7%) |
| 101–1,000 | 54/452 (11.9%) | 4/51 (7.8%) | 55/401 (13.7%) | 68/1,314 (5.2%) | 39/383 (10.2%) | 76/1,394 (5.5%) | 299/7,159 (4.2%) | 595/11,154 (5.3%) |
| > 1,000 | — | — | 27/160 (16.9%) | 50/994 (5.0%) | 15/118 (12.7%) | 40/548 (7.3%) | 286/6,206 (4.6%) | 418/8,026 (5.2%) |
| 0.002 | 0.321 | 0.206 | < 0.001 | 0.023 | 0.001 | 0.167 | < 0.001 | |
| Season | ||||||||
| Dry | 74/398 (18.6%) | 23/592 (3.9%) | 16/174 (9.2%) | 128/3,378 (3.8%) | 128/1,453 (8.8%) | 62/1,818 (3.4%) | 776/22,023 (3.5%) | 1,207/29,836 (4.0%) |
| Rainy | 207/2,043 (10.1%) | — | 147/1,062 (13.8%) | 94/3,293 (2.9%) | 0/47 (0.0%) | 125/1,872 (6.7%) | 6,024/134,334 (4.5%) | 6,597/142,651 (4.6%) |
| < 0.001 | — | 0.093 | 0.033 | 0.033 | < 0.001 | < 0.001 | < 0.001 | |
| Study arm | ||||||||
| Intervention | 157/1,525 (10.3%) | 12/392 (2.7%) | — | 94/3,467 (2.7%) | 67/741 (9.0%) | 87/1,782 (4.9%) | 3,332/77,033 (4.3%) | 3,749/84,940 (4.4%) |
| Control | 124/916 (13.5%) | 11/195 (5.6%) | — | 128/3,204 (4.0%) | 61/759 (8.0%) | 100/1,908 (5.2%) | 3,468/79,324 (4.4%) | 4,055/87,542 (4.6%) |
| 0.019 | 0.13 | — | 0.003 | 0.486 | 0.619 | 0.652 | 0.029 | |
| Abbreviations: CS, cross-sectional; RCT, randomized controlled trial. | ||||||||
Water quality measurements by study.
| Reference | Country | CFU TTC/100 mL | Log10 TTC | Number of households per TTC category (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Median | Mean ± SD | Median | < 1 | 1–10 | 11–100 | 101–1,000 | > 1,000 | |||
| Clasen et al. 2005 | Colombia | 401 | 77.8 ± 115.8 | 17 | 1.2 ± 0.9 | 1.2 | 104 (25.9) | 71 (17.7) | 127 (31.7) | 99 (24.7) | — |
| Clasen et al. 2006 | Bolivia | 101 | 35.3 ± 87.7 | 0 | 0.6 ± 0.9 | 0.0 | 64 (63.4) | 9 (8.9) | 16 (15.8) | 12 (11.9) | — |
| Peletz et al. 2011 | Zambia CS | 234 | 700.3 ± 2130.4 | 74 | 1.6 ± 1.3 | 1.9 | 71 (30.3) | 21 (9.0) | 29 (12.4) | 84 (35.9) | 29 (12.4) |
| Peletz et al. 2012 | Zambia RCT | 1,313 | 668.7 ± 1802.9 | 20 | 1.4 ± 1.3 | 1.3 | 421 (32.1) | 196 (14.9) | 240 (18.3) | 261 (19.9) | 195 (14.9) |
| Boisson et al. 2009 | Ethiopia | 234 | 451.4 ± 1792.1 | 85 | 1.7 ± 1.1 | 1.9 | 47 (20.1) | 12 (5.1) | 72 (30.8) | 79 (33.8) | 24 (10.3) |
| Boisson et al. 2010 | DR Congo | 815 | 1548.5 ± 5721.8 | 140 | 1.6 ± 1.4 | 2.2 | 236 (29.0) | 99 (12.1) | 56 (6.9) | 319 (39.1) | 105 (12.9) |
| Clasen et al. 2014 | India | 4,902 | 686.8 ± 1147.6 | 60 | 1.7 ± 1.3 | 1.8 | 1,528 (31.2) | 300 (6.1) | 874 (17.8) | 1,180 (24.1) | 1,020 (20.8) |
| Overall | 8,000 | 726.4 ± 2235.6 | 47 | 1.6 ± 1.3 | 1.7 | 2,471 (30.9) | 708 (8.8) | 1,414 (17.7) | 2,034 (25.4) | 1,373 (17.2) | |
| Abbreviations: CFU, colony forming unit; CS, cross-sectional; RCT, randomized, controlled trial; TTC, thermotolerant coliform. | |||||||||||
Adjusted odds ratios of diarrhea for log10 TTC/100 mL.
| Reference | Country | All ages | Children < 5 | ||
|---|---|---|---|---|---|
| Adj. OR (95% CI) | Adj. OR (95% CI) | ||||
| Peletz et al. 2011 | Zambia CS | 1.14 (0.93, 1.42) | 0.192 | 1.26 (0.97, 1.63) | 0.087 |
| Boisson et al. 2009 | Ethiopia | 1.42 (1.00, 2.01) | 0.049 | 1.10 (0.71, 1.71) | 0.657 |
| Clasen et al. 2006 | Bolivia | 1.62 (0.97, 2.70) | 0.063 | 1.56 (0.81, 3.04) | 0.186 |
| Clasen et al. 2005 | Colombia | 1.60 (1.24, 2.07) | < 0.001 | 1.66 (1.14, 2.41) | 0.008 |
| Peletz et al. 2012 | Zambia RCT | 1.44 (1.28, 1.63) | < 0.001 | 1.38 (1.20, 1.57) | < 0.001 |
| Boisson et al. 2010 | DR Congo | 1.21 (1.06, 1.39) | 0.006 | 1.30 (1.07, 1.57) | 0.007 |
| Clasen et al. 2014 | India | 1.04 (0.99, 1.10) | 0.099 | 1.12 (1.03, 1.21) | 0.010 |
| Combined | 1.12 (1.08, 1.18) | < 0.001 | 1.18 (1.11, 1.26) | < 0.001 | |
| Combined except India | 1.36 (1.26, 1.47) | < 0.001 | 1.33 (1.21, 1.46) | < 0.001 | |
| Abbreviations: CS, cross-sectional; RCT, randomized, controlled trial. Note: All studies were adjusted for categorical ages (< 5, 5–15, > 15) and season (rainy/dry) except Bolivia, which was adjusted only for age because all observations occurred in the dry season. | |||||
Figure 1Forest plot of adjusted odds ratios from multi-level logistic regression model with log10 TTC as a continuous predictor for all ages (A) and for children under 5 (B). All ages models are adjusted for age as a categorical variable (< 5, 5–15, > 15) and season. Models for children under 5 are adjusted for age as a continuous variable and season. The summary measures are also adjusted for study location. Study-specific point estimates are proportional to the number of observations.
Diarrhea odds ratios (95% CI) for categories of thermotolerant coliforms in household drinking water.
| Reference | Country | TTC/100 mL drinking water | ||||
|---|---|---|---|---|---|---|
| < 1 | 1 to 10 | 11 to 100 | 101 to 1,000 | > 1,000 | ||
| Peletz et al. 2011 | Zambia CS | |||||
| All ages | — | 0.71 (0.24, 2.09) | 0.84 (0.34, 2.08) | 1.28 (0.68, 2.44) | 2.13 (0.87, 5.21) | |
| Children < 5 | — | 0.26 (0.05, 1.47) | 0.84 (0.28, 2.48) | 1.60 (0.74, 3.46) | 2.31 (0.75, 7.08) | |
| Boisson et al. 2009 | Ethiopia | |||||
| All ages | — | 4.09 (0.81, 20.65) | 1.16 (0.38, 3.54) | 2.49 (0.87, 7.10) | 3.64 (0.96, 13.79) | |
| Children < 5 | — | 3.33 (0.45, 24.48) | 2.20 (0.49, 9.68) | 2.15 (0.52, 8.85) | 0.87 (0.08, 9.26) | |
| Clasen et al. 2006 | Bolivia | |||||
| All ages | — | 0.64 (0.08, 5.46) | 1.79 (0.56, 5.74) | 3.10 (0.80, 11.99) | — | |
| Children < 5 | — | 1.13 (0.11, 11.97) | 3.69 (0.79, 17.19) | 0.95 (0.09, 10.06) | — | |
| Clasen et al. 2005 | Colombia | |||||
| All ages | — | 1.69 (0.83, 3.46) | 1.98 (1.12, 3.52)* | 3.88 (1.93, 7.83)* | — | |
| Children < 5 | — | 1.15 (0.37, 3.61) | 2.34 (1.03, 5.35)* | 3.62 (1.32, 9.89)* | — | |
| Peletz et al. 2012 | Zambia RCT | |||||
| All ages | — | 1.27 (0.74, 2.18) | 1.94 (1.20, 3.15)* | 3.18 (2.02, 4.99)* | 3.33 (2.05, 5.41)* | |
| Children < 5 | — | 1.29 (0.71, 2.37) | 1.81 (1.05, 3.10)* | 2.85 (1.72, 4.71)* | 2.90 (1.68, 4.99)* | |
| Boisson et al. 2010 | DR Congo | |||||
| All ages | — | 1.12 (0.55, 2.30) | 2.00 (1.01, 3.96)* | 1.51 (0.90, 2.54) | 2.26 (1.28, 4.00)* | |
| Children < 5 | — | 1.17 (0.43, 3.17) | 2.28 (0.83, 6.24) | 1.99 (0.99, 4.00) | 2.42 (1.08, 5.46)* | |
| Clasen et al. 2014 | India | |||||
| All ages | — | 1.06 (0.78, 1.44) | 1.08 (0.88, 1.32) | 1.08 (0.90, 1.30) | 1.20 (0.99, 1.45) | |
| Children < 5 | — | 1.10 (0.65, 1.86) | 1.48 (1.06, 2.07)* | 1.11 (0.82, 1.51) | 1.62 (1.19, 2.21)* | |
| Combined | ||||||
| All ages | — | 1.02 (0.82, 1.26) | 1.21 (1.03, 1.42)* | 1.35 (1.16, 1.57)* | 1.49 (1.27, 1.76)* | |
| Children < 5 | — | 0.94 (0.68, 1.31) | 1.52 (1.20, 1.93)* | 1.50 (1.20, 1.86)* | 1.77 (1.40, 2.24)* | |
| Combined except Clasen et al. 2014 | ||||||
| All ages | — | 1.21 (0.88, 1.68) | 1.66 (1.25, 2.19)* | 2.30 (1.76, 2.99)* | 2.97 (2.17, 4.08)* | |
| Children < 5 | — | 1.02 (0.67, 1.56) | 1.81 (1.29, 2.55)* | 2.28 (1.66, 3.13)* | 2.38 (1.62, 3.51)* | |
|
Abbreviations; CS, cross-sectional; RCT, randomized, controlled trial; TTC, thermotolerant coliforms. *Significant at α = 0.05. | ||||||
Figure 2Adjusted odds ratios and 95% confidence intervals for WHO risk categories (with < 1 TTC/100 mL as references) for (A) all studies combined and (B) each study individually.